ReviewJournal of clinical medicine2022

The "FIFTY SHADOWS" of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease.

Gregorio Romero-González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.